Sauvage 1992.
Methods | Type of study: RCT. | |
Participants | Number of participants randomised:14 Losses: 2 of 14 (no details given) N = 14 Age: mean (SD) exercise group ‐ 73.38 (4.04), control group ‐ 73.83 (4.74). Sex: men. Health status as defined by authors: deconditioned Residential status of participants: Veterans Nursing Home Setting: USA. Inclusion: Recruited from Veterans Nursing Home. Aged over 60 years, independently mobile, gait and balance difficulties (Tinetti score less than 30), lower extremity weakness. Exclusion: moderate to severe dementia, asymmetrical focal neurolic deficits, lower extremity amputation, leg length discrepancies, significant systemic disease. |
|
Interventions | EXERCISE GROUP (MULTIPLE): (n = 8) PRE and aerobic conditioning (> 70% exercise stress tested maximal HR) using gym equipment and ergometers. CONTROL GROUP: (n = 6) usual activity. Duration and intensity: 45 to 75 minutes, 3 times per week x 12 weeks. Supervisor: not stated Supervision: group (3 to 4). Setting: Institutional. | |
Outcomes | Average gait velocity (cm/s) over 20 feet. (right and left).
COP movement during quiet stance ‐ eyes open, eyes closed (mm). Compliance/adherence: Compliance 95% for exercise group Adverse events: not reported |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Insufficient information to permit judgement |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgement |
Incomplete outcome data (attrition bias) All outcomes | High risk | Completers only |
Selective reporting (reporting bias) | Unclear risk | Insufficient information to permit judgement |
Other bias | Low risk | The study appears to be free of other sources of bias |
Blinding (participant) | High risk | Not possible |
Blinding (assessor) | Low risk | Assessors blinded |
Were the treatment and control group comparable at entry? | Unclear risk | Insufficient information to permit judgement |
Was the surveillance active, and of clinically appropriate duration (i.e. at least 3 months post intervention)? | High risk | Outcomes immediately post intervention only with no follow‐up |